Background: Etoposide mediates its cytotoxicity by inducing apoptosis. Thus, mechanisms which regulate apoptosis should also affect drug resistance. Oxidants and antioxidants have been shown to participate in the regulation of apoptosis. We were interested in studying whether responsiveness of acute myeloblastic leukemia (AML) cells to etoposide is mediated by oxidative stress and glutathione levels.
Introduction
Apoptosis is a process by which most chemotherapy agents mediate their cytotoxicity. Thus, mechanisms which regulate apoptosis should also affect drug resistance. There is growing evidence to suggest that oxidants and antioxidants participate in the regulation of apoptosis. Increased intracellular reactive oxygen species (ROS) are associated with apoptosis and cell death in malignant cells [1] [2] [3] . Correspondingly, various antioxidants, such as catalase, glutathione, and manganese superoxide dismutase, have been shown to protect cancer cells from death [4] [5] [6] [7] [8] [9] [10] . The glutathione redox system is one of the most important antioxidant systems and is present in all cell compartments [11] . Glutathione has an important role in the responsiveness of cancer cells to antineoplastic agents, whereby high glutathione levels are associated with drug resistance and low levels enhance sensitivity of cells to a variety of cytotoxic drugs [7, 10] . High levels of y-glutamylcysteine synthetase (Y-GCS), the rate-limiting enzyme in glutathione synthesis, have also been associated with drug resistance [12] [13] [14] .
Etoposide, a DNA topoisomerase II inhibitor, is an important anti-tumor agent in the treatment of acute myeloblastic leukemia (AML). Etoposide resistance is an increasingly prevalent clinical problem, but its mechanisms are poorly understood. The toxicity of etoposide has been related to the induction of the tumor suppressor/755 with consequent induction of apoptosis [15, 16] . In addition, the presence of wild type p53 appears to sensitize HL60 cells to etoposide through disruption by /?55/topoisomerase II alpha interactions [17] . However, it has also been suggested that etoposide may exert some of its cytotoxic activity by free radical-mediated mechanisms [18, 19] or simply as a result of a change in the cellular redox state [20, 21] . There are some suggestions that glutathione might play an important role in etoposide resistance [21] [22] [23] .
Recently, we have established two subclones of the OCI/AML-2 cell line which differ in their responsiveness to etoposide. One of these subclones is sensitive to etoposide (ES), while the other is resistant (ER). We were interested in studying whether the responsiveness of these subclones to etoposide is associated with oxidative stress and whether variability in intracellular glutathione and y-GCS contribute to etoposide resistance. The data suggest that glutathione and y-GCS are important determinants of etoposide-induced apoptosis in AML cells. incubated in annexin V-Fluos labelling solution (2% annexin-V-Fluos and 1.0 ng/ml propidium iodide in 10 mM Hepes/NaOH, pH 7.4; 140 mM NaCl; 5 mM CaCl 2 ) for 15 min at room temperature in the dark. Cells were then washed twice with Hepes buffer and analysed on a FACSort flow cytometer (Becton Dickinson, San Jose, CA)
Detection of peroxides by flow cytometry
AML cells (0.5 x 10 6 cells/ml) were cultured with or without 10 uM etoposide for 0.5, 6, 12 and 24 hours. 5 uM Dichlorohydrofluoresceindiacetate (DCFH-DA) (Molecular Probes, Inc., Eugene, OR, USA) was added to the culture medium for the last 30 minutes of treatment, and subsequently, cells were harvested, washed twice with PBS and measured for fluorescence intensity on the FACSort flow cytometer. No interference of DCFH fluorescence by etoposide was observed after the treatment of AML cells with 10 uM etoposide for 30 min.
Patients and methods

OCI/AML-2 subclones and culture
The human AML cell line OCI/AML-2 was established and characterized at the Ontario Cancer Institute, Toronto, Canada [24] (gift of Dr E. A. McCulloch). They are cultured routinely at a density of 1 x 10 6 cells/ml in a-minimal essential medium (a-MEM) (Gibco, Grand Island, NY, USA) supplemented with 10% heat-inactivated foetal bovine serum (FBS) in an atmosphere of 95% air and 5% CO 2 at 37 °C. Two subclones, etoposide-sensitive (ES) and etoposide-resistant (ER) were isolated from the parental cells in 1998 using basic culture conditions without the addition of etoposide. The subclones have retained their differential responsiveness to etoposide. The identity of these subclones as derivatives of the parental OCI/AML-2 cells has been verified by forensic-type DNA fingerprinting (Dr H. Drexler/ DSMZ, Braunschweig, Germany). The doubling time of ES and ER subclones in suspension is about 3.2 and 2.9 days, respectively.
Etoposide was purchased from Bristol-Myers Squibb (Espoo, Finland). Fresh dilutions were made in culture medium just before use to ensure constant quality of the preparations. Etoposide was used in the experiments at a concentration of 10 umol/1. In selected experiments, L-buthionine [S, R] sulfoximine (BSO) (Sigma Chemical Co., St. Louis, MO, USA) was used at a concentration of 0.5 mmol/1, which caused a significant decrease in GSH levels, but had no effect on cell viability, as analysed by trypan blue exclusion.
Determination of cell death
Cell viability was determined by the trypan blue exclusion test. At least 500 cells/sample were counted. Additionally, the microtiter plate/ tetrazolium dye (XTT) colorimetric assay (Boehringer Mannheim, Mannheim. Germany) was used to quantify the cytotoxic effects of etoposide on blast cells. Briefly, 1 x 10 3 blast cells in 0.1 ml of modified Eagle MEM (Life Technologies, Gaithersburg, MD, USA) with 10% FBS were seeded in the wells of a 96-well flat-bottomed microtitre plate (Falcon. Becton Dickinson, NJ, USA). The cultures were incubated for 24 hours at 37 C C. After the incubation, 50 ul of the XTT labelling mixture was added to each of the wells. After 24 hours of incubation in the same atmospheric conditions as above, the absorbance of the samples was measured with a spectrophotometric plate reader (Victor 11 . Wallac, Turku, Finland) at 450 nm. Cytotoxicity was calculated by the following formula: percentage of cytotoxicity = [1 -(absorbance of experimental wells/absorbance of control wells)] x 100.
Apoptotic and necrotic cells were discriminated by fluorescein isothiocyanate (FITC)-conjugated annexin V (Boehringer Mannheim. Mannheim, Germany) binding and propidium iodide uptake, respectively, in a flow cytometer, as described previously [25] . Cells were harvested, washed twice with phosphate-buffered saline (PBS) and
Determination of glutathione and gamma-glutamylcysteine synthetase
Total glutathione was determined spectrophotometrically following the reduction of 5,5'-dithiobis(2-nitrobenzoic)acid by NADPH in the presence of glutathione reductase [26] . Glutathione content is expressed as pmol/1 x 10 6 cells. The activity of y-GCS was determined using a modification of the previously described HPLC method [27] , which measures the end product y-glutamylcysteine following conjugation with monobromobimane Cells were lysed by repeated freezing and thawing in 100 mM Tris-HCl buffer (pH 8.2) containing 50 mM KC1, 20 mM MgCl 2 and 2 mM EDTA. The lysates were centrifuged at 15,000 xg for 15 min at 4 °C and the supernatants were filtered through Micro Bio-Spin Chromatography Columns (Bio-Rad, Hercules, CA, USA) Aliquots of the supernatant were added to the reaction mixture (100 mM Tris-HCl, pH 8.2, 50 mM KC1, 20 mM MgCl 2 , 6 mM DTT, 3 mM L-cysteine, 15 mM glutamic acid and 10 mM ATP) and incubated at 37 °C for 30 min. 50 ul of incubation mixture was removed and added to 50 ul of 30 mM monobromobimane in 50 mM N-ethylmorpholine, pH 8.4. After derivatization for 5 min in the dark at room temperature, the reaction was stopped with 10 ul of 100% trichloroacetic acid. After centnfugation, 1 ul of supernatant was injected into a Waters Novapak C-18 HPLC column (4 mm, 3.9 x 150 mm) with an isocratic mobile phase consisting of 4% acetonitrile, 0.25% acetic acid and 0.25% perchloric acid (pH 3.7). The fluorescent y-glutamylcysteine-bimane conjugate was detected with a Shimadzu RF-10 AxL spectrofluorometer (excitation and emission wavelengths of 394 and 480 nm, respectively). The product was quantified by comparison to y-glutamylcysteine (Bachem, Budendorf, Switzerland) standards derivatized and analysed as above. The protein concentration was determined from filtered cell lysates using Bio-Rad DC protein assay kit.
Western blotting
Cells were harvested and washed twice with ice-cold PBS. Nuclear extracts of 1 x 10 7 cells were prepared for PARP detection as described previously [25] , For y-GCS detection, 1.5 x 10 6 cells were lysed in 60 ul of distilled water, and after 10 min on ice. lysates were centrifuged at 750 x g for 4 min, and the supernatant was collected and stored at -80 = C Protein contents were determined by Bio-Rad protein assay (Bio-Rad Laboratories, Hercules, CA. USA). Nuclear extracts (30 ug) or whole-cell lysates (40 ug) were subjected to 12% SDS-PAGE (BioRad Laboratories) and transferred to Hybond nitrocellulose membranes (Amersham Life Science, Buckinghamshire, UK). After blocking for 30 min with 8% dried fat-free milk inTris-buffered saline-Tween (TBS-T) (20 mM Tris-HCl, pH 7.6; 137 mM NaCl: 0.1% Tween-20), the membranes were incubated for 1 hour with the primary antibodies, either mouse anti-PARP (Pharmingen, San Diego, CA, USA) or rabbit antisera raised against the peptide ETLQEKGERTNPNHPTL (1:40.000). which recognizes the 73 kDa y-GCS catalytic subunit [28] . This was followed by treatment with a secondary antibody (1:30,000) conjugated to horseradish peroxidase (Amersham). Immunoreactivity was detected by an enhanced chemiluminescence (ECL) system (Amersham). P-actin expression was detected with a monoclonal antiactin antibody (1:30,000).
Results
Etoposide-induced cytotoxicity
Cell death was observed by trypan blue exclusion in the ES subclone after 12-hour exposure and in the ER subclone after 24-hour exposure to etoposide (Figure la) . The trypan blue exclusion and annexin V assays were highly correlated (Figure lb) . The annexin V assay indicated that most of the dead cells were apoptotic and only a minority of the cells were necrotic (data not shown). After 24 hours of exposure to etoposide, an increase in cytotoxicity was observed in both subclones being 76% ± 8% (mean ± SD, n = 3) in ES and 21% ± 5% in ER subclones by the XTTassay. 
Effect of etoposide on cleavage of poly(ADP-ribose)polymerase (PARP)
Cleavage of PARP is a sign of caspase-3 activation and apoptosis. Complete cleavage of PARP was observed after 12-hour exposure to etoposide in ES cells. In contrast, no PARP cleavage was detectable by 12 hours in the ER cells, and only partial cleavage was observed after 24 hours (Figure 2) . The experiments were repeated three times with similar results.
Effect of etoposide on the generation of peroxides
Both cell lines produced peroxides in basal growth conditions, as shown by DCHF-DA fluorescence. An increase in peroxides was observed after 12-hour exposure in both cell lines, although it was more pronounced in the ES subclone (4.5 ± 1.5 fold; mean ± SD, n = 3) than in the ER subclone (1.7 ± 0.3-fold). A representative flow cytometric histogram is presented in Figure 3 . Increased ROS generation (1.7-fold) was maintained in the ER cells for at least 24 hours, after which it was no longer technically possible to detect it in the ES cells. The experiments were repeated at least five times with similar results.
Influence of etoposide on glutathione
The basal levels of glutathione were 3261 ± 688 pmol/ 1 x 10 6 cells in the ES and 4357 ± 82 pmol/I x 10 6 cells in the ER subclone. After 12 and 24 hours of exposure to etoposide, the glutathione levels decreased to 61% and 23% in ES cells, while in ER cells the corresponding values were 111% and 85% of control values (Figure 4 
Effect of etoposide on y-GCS
The basal activities of y-GCS were 1580 ± 160 pmol/ min/mg of protein (mean ± SD, n = 3) in ES cells and 2280 ± 194 pmol /min/mg of protein in ER cells. y-GCS activity was maintained within 83%-106% of control in the ES subclone and within 92%-108% in the ER subclone during 12-hour and 24-hour exposure, respectively. Western blot analysis showed that the 73 kDa catalytic domain of y-GCS decreased during etoposide exposure in the ES cells (Figure 5a ). Furthermore, a cleaved band appeared after 12-hour exposure in ES cells and after 24-hour exposure in ER cells (Figure 5b ) coincident with caspase activation and apoptosis. These Western blotting experiments were repeated four times with similar results.
Effect of BSO, an inhibitor of y-GCS, on glutathione levels
Glutathione was depleted to 8% ± 10% and 42% ± 24% (mean ± SD, n = 3) after 24-hour exposure to 0.5 mM BSO in the ES and ER subclones, respectively. By 48 hours, glutathione remained low in the ES subclone and decreased to 14% ± 6% of control levels in the ER subclone. During BSO exposure, the viability of both cell lines was always over 90% as indicated by trypan blue exclusion.
Effect of BSO on apoptosis induced by etoposide
The AML subclones were exposed first to 0.5 mM BSO for 24 hours, and subsequently, etoposide was added to the culture medium for another 24 hours. BSO itself did not cause apoptosis in either of the cell lines. However, it did enhance the effect of etoposide, particularly in the ER subclone, where the number of annexin V-positive cells increased by 62%. This enhancement was also seen in the case of ES cells, even though cells treated with etoposide alone were over 90% annexin V positive. The experiments were repeated twice with comparable results.
Discussion
In the present study, we showed that the cellular redox state is associated with resistance to etoposide in AML cells. Although etoposide increased peroxide generation and induced oxidative stress in both of the OCI/AML-2 subclones investigated, the subclone with higher basal glutathione and y-GCS levels was more resistant against etoposide-induced apoptosis. In addition to its recognised effects on topoisomerase II, etoposide may exert cell death via free radical formation and oxidative stress [18, 19] . Etoposide itself is a phenol derivative and has been suggested to function as both an antioxidant [22, 29] and an oxidant since its phenoxyl radicals metabolites [22] may cause oxidative stress [30] and ROS generation [31] [32] [33] . These metabolites also react with cellular thiols [22, 23] , which might contribute to etoposide's cytotoxicity.
Indeed, we have shown here that exposure to etoposide increases peroxide formation in AML cells. Increased generation of ROS per se did not automatically lead to apoptosis as both ES and ER cells displayed an increase in ROS with etoposide exposure. However the etoposide-induced increase in ROS was less in the ER cells than ES cells. This may be related to the fact that ER cells have higher basal levels of glutathione, and perhaps more importantly, a 50% higher basal y-GCS activity. There are many reports showing that high basal glutathione levels protect cells from various cytotoxic agents, while low glutathione levels correlate with enhanced sensitivity to such agents [7, 10] . In the case of etoposide, Lizard and co-workers found that exogenous glutathione and N-acetyl-L-cysteine, by providing cysteine for glutathione synthesis, were able to diminish the toxic effects of etoposide [21] . Furthermore, depletion of glutathione with BSO caused increased sensitivity of breast, ovarian and non-small-cell lung carcinoma cell line cells to etoposide [33, 34] . These reports suggest that glutathione has some role in etoposide resistance. On the other hand, intracellular glutathione levels did not correlate with the in vitro responsiveness of acute lymphatic leukemia cells to etoposide [35] , and in another study, glutathione depletion by BSO did not lead to increased sensitivity of various leukemia cell lines to etoposide [36] . In the present study, the ER subclone contained a higher glutathione level than the ES subclone. Additionally, glutathione depletion by BSO abrogated etoposide resistance in this subclone and was also able to increase the sensitivity of ES cells to etoposide. At least in these AML subclones the glutathione content was significantly associated with the responsiveness of cells to etoposide. The reasons for this resistance in the ER subclone are likely to be multifaceted and could include enhanced ROS scavenging; the ability of glutathione to positively influence the export of etoposideglucuronide conjugate by the multidrug resistance pump [37] ; lower ceramide levels through inhibition of neutral sphingomyelinase by glutathione [38, 39] ; or the direct inhibitory effect of glutathione on either caspase activity [40] or AP24 mediated DNA fragmentation [41] .
The increase in ROS following etoposide treatment was significantly higher in the ES cells than in the ER cells. This could be due to their relative capacities for metabolising etoposide to its reactive intermediates, or to peroxide scavenging, which may be determined in part by glutathione content. Alternatively, the accumulation of intracellular ROS may reflect the onset of apoptotic processes which include increased production of superoxide anion by mitochondria [42] , and/or export of glutathione from the cell [43] . Glutathione export coupled with increased ROS generation would cause depletion of cellular reducing capacity during apoptosis.
Increased y-GCS expression and activity has also been connected with drug resistance in the case of cisplatin [13] , melphalan [12] and doxorubicin [14] . In the present study, neither of the AML subclones displayed an increase in y-GCS expression or an increase in its activity with etoposide treatment. Hence, the difference between the subclones in the resistance to etoposide may be associated with the basal level of y-GCS, which was higher in the ER cells than in the ES cells. Furthermore, as mentioned previously, inhibition of y-GCS by BSO led to a dramatic increase in susceptibility to etoposideinduced apoptosis in the ER subclone.
Interestingly, the catalytic subunit of y-GCS is cleaved during apoptosis. Significant cleavage (approximately 60%) occurred by 12 hours of treatment with etoposide in the ES subclone, while minimal cleavage (<25%) occurred in the ER subclone and this was apparent only after 24 hours of etoposide exposure. The timing and extent of y-GCS cleavage suggests a causal relationship with glutathione depletion in etoposide-treated cells. It is possible that in AML cells, y-GCS is one of the target proteins of the apoptotic machinery (as is PARP) and that its cleavage helps to insure apoptosis. Indeed, in other studies, we have found that cleavage of the y-GCS catalytic subunit is a common feature in other models of apoptosis (including both receptor mediated and chemical induced apoptosis), that it is caspase mediated, and that it is specific to the catalytic subunit, as no cleavage of the regulatory subunit is apparent (Franklin et al., manuscript in preparation).
It is also interesting that although etoposide caused significant oxidative stress, this did not lead to increased expression of y-GCS. Many other studies have shown induction of y-GCS by agents known to induced oxidative stress [44, 45] . It may be that etoposide inhibits y-GCS induction through its effects on transcription factors or on the transcriptional machinery itself.
In spite of the cleavage of the catalytic subunit of the enzyme, the activity of y-GCS was not decreased with etoposide exposure. However, under the assay conditions used, the influence of the regulatory subunit of y-GCS on catalytic activity would not have been detected. Furthermore, it is unclear whether etoposide treatment might have different effects on the native versus the cleaved forms the enzyme. While it is possible that the y-GCS cleavage product retains full enzymatic activity in vitro, these data do not exclude the possibility that cleavage of the catalytic subunit results in the functional inactivation of y-GCS holoenzyme under physiological conditions in vivo. Experiments are currently underway to further investigate the functional consequences of this cleavage event.
In conclusion, etoposide induces oxidative stress in AML cells. High basal glutathione levels and y-GCS activity appear to protect AML cells from etoposideinduced cell death. The lack of y-GCS induction and cleavage of the catalytic subunit of this enzyme during etoposide exposure might exacerbate glutathione depletion and potentiate apoptosis in etoposide-treated AML cells.
